Anti-inflammatory activity of Taraxacum officinale

Journal of Ethnopharmacology

Volumn 115, Issue 1, 2008, Pages 82-88

  Jeon, Hye Jin ^a   Kang, Hyun Jung ^b   Jung, Hyun Joo ^a   Kang, Young Sook ^a   Lim, Chang Jin ^b   Kim, Young Myeong ^b   Park, Eun Hee ^a  

^a Sookmyung Women's University   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

Anti inflammatory; Anti nociceptive; Antioxidant; Cyclooxygenase 2; Inducible nitric oxide synthase; Nitric oxide; Reactive oxygen species; Taraxacum officinale

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ACETIC ACID; ACETIC ACID ETHYL ESTER; ALCOHOL; BUTANOL; CARRAGEENAN; HERBACEOUS AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; TARAXACUM OFFICINALE EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BLOOD VESSEL PERMEABILITY; CHORIOALLANTOIS; CONTROLLED STUDY; DANDELION; DOSE RESPONSE; DRUG INHIBITION; DRUG ISOLATION; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; WRITHING TEST;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICALS; LEUKOCYTES; MALE; MEDICINE, TRADITIONAL; MICE; MICE, INBRED ICR; NITRIC OXIDE; PAIN; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; TARAXACUM;

MUS; TARAXACUM OFFICINALE;

EID: 36448953875     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.09.006     Document Type: Article

References (32)

1. Ahmad V.U., Yasmeen S., Ali Z., Khan M.A., Choudhary M.I., Akhtar F., Miana G.A., and Zahid M. Taraxacin, a new guaianolide from Taraxacum wallichii. Journal of Natural Products 63 (2000) 1010-1011
2. Chesrown S.E., Monnier J., Visner G., and Nick H.S. Regulation of inducible nitric oxide synthase mRNA levels by LPS, INF-gamma, TGF-beta, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochemical and Biophysical Research Communications 200 (1994) 126-134
3. Ghosh A.K., Hirasawa N., Niki H., and Ohuchi K. Cyclooxygenase-2-mediated angiogenesis in carrageenan-induced granulation tissue in rats. Journal of Pharmacology and Experimental Therapeutics 295 (2000) 802-809
4. Griffioen A.W., and Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacological Reviews 52 (2000) 237-268
5. Hu C., and Kitts D.D. Antioxidant, prooxidant, and cytotoxic activities of solvent-fractionated dandelion (Taraxacum officinale) flower extracts in vitro. Journal of Agricultural and Food Chemistry 51 (2003) 301-310
6. Hu C., and Kitts D.D. Luteolin and luteolin-7-O-glucoside from dandelion flower suppress iNOS and COX-2 in RAW264.7 cells. Molecular and Cellular Biochemistry 265 (2004) 107-113
7. Hu C., and Kitts D.D. Dandelion (Taraxacum officinale) flower extract suppresses both reactive oxygen species and nitric oxide and prevents lipid peroxidation in vitro. Phytomedicine 12 (2005) 588-597
8. Iurlaro M., Benelli R., Masiello L., Rosso M., Santi L., and Albini A. Beta interferon inhibits HIV-1 Tat-induced angiogenesis: synergism with 13-cis retinoic acid. European Journal of Cancer 34 (1998) 570-576
9. Jachak S.M. Cyclooxygenase inhibitory natural products: current status. Current Topics in Medicinal Chemistry 13 (2006) 659-678
10. Kim H.-M., Oh C.-H., and Chung C.-K. Activation of inducible nitric oxide synthase by Taraxacum officinale in mouse peritoneal macrophages. General Pharmacology 32 (1999) 683-688
11. Kim H.-M., Shin H.-Y., Lim K.-H., Ryu S.-T., Shin T.-Y., Chae H.-J., Kim H.-R., Lyu Y.-S., and An N.-H. Taraxacum officinale inhibits tumor necrosis factor-α production from rat astrocytes. Immunopharmacology and Immunotoxicology 22 (2000) 519-530
12. Kim B.-C., Mamura M., Choi K.S., Calabretta B., and Kim S.-J. Transforming growth factor beta 1 induces apoptosis through cleavage of BAD in a Smad3-dependent mechanism in FaO hepatoma cells. Molecular and Cellular Biology 22 (2002) 1369-1378
13. Kisiel W., and Barszcz B. Further sesquiterpenoids and phenolics from Taraxacum officinale. Fitoterapia 71 (2000) 269-273
14. Koo H.-N., Hong S.-H., Song B.-K., Kim C.-H., Yoo Y.-H., and Kim H.-M. Taraxacum officinale induces cytotoxicity through TNF-α and IL-1α secretion in HepG2 cells. Life Sciences 74 (2004) 1149-1157
15. Leu Y.-L., Wang Y.-L., Huang S.-C., and Shi L.-S. Chemical constituents from roots of Taraxacum formosanum. Chemical and Pharmaceutical Bulletin 53 (2005) 853-855
16. Michalska K., and Kisiel W. Sesquiterpene lactones from Taraxacum obovatum. Planta Medica 69 (2003) 181-183
17. Olajide O.A., Awe S.O., Makinde J.M., Ekhelar A.I., Olusola A., Morebise O., and Okpako D.T. Studies on the anti-inflammatory, antipyretic and analgesic properties of Alstonia boonei stem bark. Journal of Ethnopharmacology 71 (2000) 179-186
18. Park E.-H., Joo M.-H., Kim S.-H., and Lim C.-J. Antiangiogenic activity of Gardenia jasminoides fruit. Phytotherapy Research 17 (2003) 961-962
19. Risau W. Differentiation of endothelium. FASEB Journal 9 (1995) 926-933
20. 2 in cultured endothelial cells. Archives of Biochemistry and Biophysics 302 (1993) 348-355
21. Schutz K., Carle R., and Schieber A. Taraxacum-a review on its phytochemical and pharmacological profile. Journal of Ethnopharmacology 107 (2006) 313-323
22. Sedgwick A.D., and Lees P. Studies of eicosanoid production in the air pouch model of synovial inflammation. Agents and Actions 18 (1986) 429-438
23. Seo S.-W., Koo H.-N., An H.-J., Kwon K.-B., Lim B.-C., Seo E.-A., Ryu D.-G., Moon G., Kim H.-Y., Kim H.-M., and Hong S.-H. Taraxacum officinale protects against cholecystokinin-induced acute pancreatitis in rats. World Journal of Gastroenterology 11 (2005) 597-599
24. Sherman M.P., Aeberhard E.E., Wong V.Z., Griscavage J.M., and Ignarro L.J. Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochemical and Biophysical Research Communications 191 (1993) 1301-1308
25. Singh V.K., Mehrotra S., Narayan P., Pandey C.M., and Agarwal S.S. Modulation of autoimmune diseases by nitric oxide. Immunologic Research 22 (2000) 1-19
26. Song Y.S., Kim S.H., Sa J.H., Jin C., Lim C.-J., and Park E.-H. Anti-angiogenic and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum. Journal of Ethnopharmacology 90 (2004) 17-20
27. Takasaki M., Konoshima T., Tokuda H., Masuda K., Arai Y., Shiojima K., and Ageta H. Anti-carcinogenic activity of Taraxacum plant. 1. Biological and Pharmaceutical Bulletin 22 (1999) 602-605
28. Tong Y., Zhang X., Zhao W., Zhang Y., Lang J., Shi Y., Tan W., Li M., Zhang Y., Tong L., Lu H., Lin L., and Ding J. Anti-angiogenic effects of shiraiachrome A, a compound isolated from a Chinese folk medicine used to treat rheumatoid arthritis. European Journal of Pharmacology 494 (2004) 101-109
29. Vogel H.G., and Vogel W.H. Drug Discovery and Evaluations, Pharmacological Assays (1997), Springer, Berlin pp. 402-403
30. Whittle B.A. The use of changes in capillary permeability in mice to distinguish between narcotic and nonnarcotic analgesics. British Journal of Pharmacology and Chemotherapeutics 22 (1964) 246-253
31. Williams C.A., Goldstone F., and Greenham J. Flavonoids, cinnamic acids and coumarins from the different tissues and medicinal preparations of Taraxacum officinale. Phytochemistry 42 (1996) 121-127
32. Zhu M., Wong P.Y., and Li R.C. Effects of Taraxacum mongolicum on the bioavailability and disposition of ciprofloxacin in rats. Journal of Pharmaceutical Sciences 88 (1999) 632-634